Terms: = Uterine cancer AND DDX10, HRH-J8, 1662, ENSG00000178105, Q13206 AND Treatment
4 results:
1. Analysis of risk factors for recurrence in infertile endometrial cancer patients after
Wei H; Pan N; Wang Y; Ma C
Front Endocrinol (Lausanne); 2023; 14():1224622. PubMed ID: 38075071
[TBL] [Abstract] [Full Text] [Related]
2. Bone Metastases of Endometrial Carcinoma Treated by Surgery: A Report on 13 Patients and a Review of the Medical Literature.
Wang J; Dai Y; Ji T; Guo W; Wang Z; Wang J
Int J Environ Res Public Health; 2022 Jun; 19(11):. PubMed ID: 35682407
[TBL] [Abstract] [Full Text] [Related]
3. Progestin intrauterine device and GnRH analogue for uterus-sparing treatment of endometrial precancers and well-differentiated early endometrial carcinoma in young women.
Minig L; Franchi D; Boveri S; Casadio C; Bocciolone L; Sideri M
Ann Oncol; 2011 Mar; 22(3):643-649. PubMed ID: 20876910
[TBL] [Abstract] [Full Text] [Related]
4. Phase II study of irinotecan and cisplatin as first-line chemotherapy in advanced or recurrent cervical cancer.
Sugiyama T; Yakushiji M; Noda K; Ikeda M; Kudoh R; Yajima A; Tomoda Y; Terashima Y; Takeuchi S; Hiura M; Saji F; Takahashi T; Umesaki N; Sato S; Hatae M; Ohashi Y
Oncology; 2000; 58(1):31-7. PubMed ID: 10644938
[TBL] [Abstract] [Full Text] [Related]
